Related references
Note: Only part of the references are listed.Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization
Luca Mastracci et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3
Mengxiao Xie et al.
JOURNAL OF AUTOIMMUNITY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity
Chien-Chun Steven Pai et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism
Yannick Degboe et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor-infiltrating human CD4(+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
Mojgan Ahmadzadeh et al.
SCIENCE IMMUNOLOGY (2019)
Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer
Chang Li et al.
CANCER LETTERS (2018)
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1
Helena J. Janse van Rensburg et al.
CANCER RESEARCH (2018)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
Xinyi Guo et al.
NATURE MEDICINE (2018)
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study
Luana Calabro et al.
LANCET RESPIRATORY MEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells
Linda Quatrini et al.
NATURE IMMUNOLOGY (2018)
Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells
Naoki Takasaka et al.
JCI INSIGHT (2018)
Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment
Yohko Kitagawa et al.
NATURE IMMUNOLOGY (2017)
Cancer-FOXP3 directly activated CCL5 to recruit FOXP3+ Treg cells in pancreatic ductal adenocarcinoma
X. Wang et al.
ONCOGENE (2017)
Non-Smad Signaling Pathways of the TGF-β Family
Ying E. Zhang
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho et al.
IMMUNITY (2017)
Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) 3 and is essential for mouse palatogenesis
Bill X. Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
Chunwan Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
Shucai Yang et al.
MOLECULAR CANCER (2017)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β
Kevin M. Hart et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TGF-β Family Signaling in Tumor Suppression and Cancer Progression
Joan Seoane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Targeting TGF-β Signaling for Therapeutic Gain
Rosemary J. Akhurst
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
Simon J. Hogg et al.
CELL REPORTS (2017)
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Angel Garcia-Diaz et al.
CELL REPORTS (2017)
The MLL1-H3K4me3 Axis-Mediated PD-L1 Expression and Pancreatic Cancer Immune Evasion
Chunwan Lu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer Patient
Hao Jin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immunotherapy in pancreatic ductal adenocarcinoma: an emerging entity?
I. H. Sahin et al.
ANNALS OF ONCOLOGY (2017)
Regulatory T-cell heterogeneity and the cancer immune response
Kirsten A. Ward-Hartstonge et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Human lung tumor FOXP+ Tregs upregulate four Treg-locking transcription factors
Tatiana Akimova et al.
JCI INSIGHT (2017)
Reenergizing T cell anti-tumor immunity by harnessing immunometabolic checkpoints and machineries
Ping-Chih Ho et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
CCR4 mediated chemotaxis of regulatory T cells suppress the activation of T cells and NK cells via TGF-β pathway in human non-small cell lung cancer
Wei Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease
Lei Zhu et al.
GASTROENTEROLOGY RESEARCH (2017)
Control of PD-L1 Expression by Oncogenic Activation of the AKT-mTOR Pathway in Non-Small Cell Lung Cancer
Kristin J. Lastwika et al.
CANCER RESEARCH (2016)
PD-1 expression on dendritic cells suppresses CD8(+) T cell function and antitumor immunity
Tong Seng Lim et al.
ONCOIMMUNOLOGY (2016)
Interfering with CCL5/CCR5 at the Tumor-Stroma Interface
Vincenzo Bronte et al.
CANCER CELL (2016)
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Niels Halama et al.
CANCER CELL (2016)
Deubiquitination and Stabilization of PD-L1 by CSN5
Seung-Oe Lim et al.
CANCER CELL (2016)
TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia
Haojian Zhang et al.
CELL STEM CELL (2016)
Risk factors for lung cancer worldwide
Jyoti Malhotra et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells
Marco De Simone et al.
IMMUNITY (2016)
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
Margaretha G. M. Roemer et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
Erin A. Marshall et al.
MOLECULAR CANCER (2016)
Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
Keisuke Kataoka et al.
NATURE (2016)
Immunometabolism of regulatory T cells
Ryan Newton et al.
NATURE IMMUNOLOGY (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice
Stefanie N. Linch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
TGF-β Signaling from Receptors to Smads
Akiko Hata et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
TGFβ-dependent expression of PD-1 and PD-L1 controls CD8+ T cell anergy in transplant tolerance
Marije Baas et al.
ELIFE (2016)
Cancer cell-derived IL-1 induces CCL22 and the recruitment of regulatory T cells
Gabriela Maria Wiedemann et al.
ONCOIMMUNOLOGY (2016)
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non-Small-Cell Lung Cancer A Review
Adrian G. Sacher et al.
JAMA ONCOLOGY (2016)
The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients
Chun-yang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Serum chemokine network correlates with chemotherapy in non-small cell lung cancer
Dawei Yang et al.
CANCER LETTERS (2015)
Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment
R. Zaynagetdinov et al.
CANCER RESEARCH (2015)
Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
Alan Serrels et al.
CELL (2015)
Molecular Pathways: Targeting the CXCR4-CXCL12 Axis-Untapped Potential in the Tumor Microenvironment
Stefania Scala
CLINICAL CANCER RESEARCH (2015)
Phase Ia Study of FoxP3+ CD4 Treg Depletion by Infusion of a Humanized Anti-CCR4 Antibody, KW-0761, in Cancer Patients
Koji Kurose et al.
CLINICAL CANCER RESEARCH (2015)
Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer
Dermot S. O'Callaghan et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
IL-10 Potentiates Differentiation of Human Induced Regulatory T Cells via STAT3 and Foxo1
Peter Hsu et al.
JOURNAL OF IMMUNOLOGY (2015)
Loss of RUNX3 expression promotes cancer-associated bone destruction by regulating CCL5, CCL19 and CXCL11 in non-small cell lung cancer
Hyun-Jeong Kim et al.
JOURNAL OF PATHOLOGY (2015)
Increase in Activated Treg in TIL in Lung Cancer and In Vitro Depletion of Treg by ADCC Using an Antihuman CCR4 mAb (KM2760)
Koji Kurose et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Excess TGF-β mediates muscle weakness associated with bone metastases in mice
David L. Waning et al.
NATURE MEDICINE (2015)
Refining the treatment of NSCLC according to histological and molecular subtypes
Anish Thomas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Kim C. Ohaegbulam et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis
D. L. Boyle et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
Gregory L. Beatty et al.
CLINICAL CANCER RESEARCH (2015)
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
Mohammad Atefi et al.
CLINICAL CANCER RESEARCH (2014)
PD-1 regulates extrathymic regulatory T-cell differentiation
Xiufen Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Human CD14+CTLA-4+ Regulatory Dendritic Cells Suppress T-Cell Response by Cytotoxic T-Lymphocyte Antigen-4-Dependent IL-10 and Indoleamine-2,3-Dioxygenase Production in Hepatocellular Carcinoma
Yanmei Han et al.
HEPATOLOGY (2014)
Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs
Cezmi A. Akdis et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Thymic Medullary Epithelium and Thymocyte Self-Tolerance Require Cooperation between CD28-CD80/86 and CD40-CD40L Costimulatory Pathways
Joy A. Williams et al.
JOURNAL OF IMMUNOLOGY (2014)
miR141-CXCL1-CXCR2 Signaling-Induced Treg Recruitment Regulates Metastases and Survival of Non-Small Cell Lung Cancer
Mingming Lv et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Neoadjuvant chemo-immunotherapy modifies CD4+CD25+ regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients
Andreas Pircher et al.
LUNG CANCER (2014)
TREG-cell therapies for autoimmune rheumatic diseases
Makoto Miyara et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4(+) T cells
Susanne A. Hahn et al.
BLOOD (2013)
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Hua Zhang et al.
BLOOD (2013)
Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
Eveline M. Dijkgraaf et al.
CANCER RESEARCH (2013)
Tumor-Specific Cytotoxic T Cells Are Crucial for Efficacy of Immunomodulatory Antibodies in Patients with Lung Cancer
Joachim G. Aerts et al.
CANCER RESEARCH (2013)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
An Inherently Bifunctional Subset of Foxp3+ T Helper Cells Is Controlled by the Transcription Factor Eos
Madhav D. Sharma et al.
IMMUNITY (2013)
FOXP3 expression in tumor cells and implications for cancer progression
Tiziana Triulzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma
Tyler R. Simpson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Genetic alterations defining NSCLC subtypes and their therapeutic implications
Larissa A. Pikor et al.
LUNG CANCER (2013)
Regulatory T cells: recommendations to simplify the nomenclature
Abul K. Abbas et al.
NATURE IMMUNOLOGY (2013)
Single-cell sequencing-based technologies will revolutionize whole-organism science
Ehud Shapiro et al.
NATURE REVIEWS GENETICS (2013)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Esra A. Akbay et al.
CANCER DISCOVERY (2013)
Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer
Julie R. Brahmer et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Effects of conventional therapeutic interventions on the number and function of regulatory T cells
Mario Roselli et al.
ONCOIMMUNOLOGY (2013)
Induced CD4+Foxp3+ Regulatory T Cells in Immune Tolerance
Angelina M. Bilate et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Regulatory T Cells: Mechanisms of Differentiation and Function
Steven Z. Josefowicz et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
Pengyuan Yang et al.
CANCER CELL (2012)
Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Melody A. Swartz et al.
CANCER RESEARCH (2012)
Constitutive Clathrin-mediated Endocytosis of CTLA-4 Persists during T Cell Activation
Omar S. Qureshi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
STAT3 Protein Interacts with Class O Forkhead Transcription Factors in the Cytoplasm and Regulates Nuclear/Cytoplasmic Localization of FoxO1 and FoxO3a Proteins in CD4+ T Cells
Hyun-Mee Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
Thomas J. Lynch et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Smad3 binding to the foxp3 enhancer is dispensable for the development of regulatory T cells with the exception of the gut
Susan M. Schlenner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Pulmonary CCL18 Recruits Human Regulatory T Cells
Cecile Chenivesse et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)
Nasrollah Erfani et al.
LUNG CANCER (2012)
Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells
Hiroyuki Tao et al.
LUNG CANCER (2012)
A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens
Helene Pere et al.
BLOOD (2011)
Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy
Takami Sato et al.
IMMUNOLOGIC RESEARCH (2011)
CD103 is a hallmark of tumor-infiltrating regulatory T cells
David Anz et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice
Christian Weber et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
High TCR Stimuli Prevent Induced Regulatory T Cell Differentiation in a NF-κB-Dependent Manner
Luciana L. Molinero et al.
JOURNAL OF IMMUNOLOGY (2011)
The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis Emphasis on Non-small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Polymorphisms of key chemokine genes and survival of non-small cell lung cancer in Chinese
Hongxia Ma et al.
LUNG CANCER (2011)
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Andrea Facciabene et al.
NATURE (2011)
The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells
Erika Cretney et al.
NATURE IMMUNOLOGY (2011)
Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells
Yohsuke Harada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Role of SMAD and Non-SMAD Signals in the Development of Th17 and Regulatory T Cells
Ling Lu et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome
Michael Gobert et al.
CANCER RESEARCH (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Down-regulation of Gfi-1 expression by TGF-β is important for differentiation of Th17 and CD103+ inducible regulatory T cells
Jinfang Zhu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Effector/Memory but Not Naive Regulatory T Cells Are Responsible for the Loss of Concomitant Tumor Immunity
Yung-Chang Lin et al.
JOURNAL OF IMMUNOLOGY (2009)
Disruption of CCR5-Dependent Homing of Regulatory T Cells Inhibits Tumor Growth in a Murine Model of Pancreatic Cancer
Marcus C. B. Tan et al.
JOURNAL OF IMMUNOLOGY (2009)
HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism
Olivier Manches et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells
Li Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 trafficking and surface expression
Elke Valk et al.
TRENDS IN IMMUNOLOGY (2008)
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer
Yukiko Tone et al.
NATURE IMMUNOLOGY (2008)
Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17
Martha M. Monick et al.
JOURNAL OF IMMUNOLOGY (2007)
TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells
Song Guo Zheng et al.
JOURNAL OF IMMUNOLOGY (2006)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
